CBX8 knockdown and overexpressing cell lines were generated in glioblastoma (U-251 MG), breast cancer (MDA-MB-231), and lung cancer (A549), and CBX8 expression levels were validated by quantitative reverse-transcriptase PCR (qRT-PCR) and western blotting (Figure S2). This evidence concerns the gene CBX8 and lung carcinoma.